©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Figure 6 He-He-Shu-Yang formula inhibits nicotinamide adenine dinucleotide phosphate oxidase 4 expression, intracellular reactive oxygen species generation, and nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3 inflam masome activation in transforming growth factor-beta 1-induced LX2 cells.
bP < 0.01 vs control group; cP < 0.05, dP < 0.01 vs model group. A: Representative western blot of nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) expression in each group. Protein levels were normalized to β-actin; B: Quantitation of NOX4 expression in each group based on the blot in panel A; C: Relative mRNA levels of NOX4 in the various groups; D: Intracellular reactive oxygen species levels as assessed using fluorescence microscopy; E: Mean fluorescence intensity of reactive oxygen species; F: Relative mRNA levels of nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3 in each group; G: Relative mRNA levels of Interleukin-1β in each group. NOX4: Nicotinamide adenine dinucleotide phosphate oxidase 4; TGF-β: Transforming growth factor-beta 1; ROS: Reactive oxygen species; NLRP3: Nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3; IL-1β: Interleukin-1β.
- Citation: Zeng FL, Shi MJ, Mo YS, Xiao HM, Xie YB, Chi XL. He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro. World J Hepatol 2025; 17(12): 112835
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/112835.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.112835